We present a case of a 15-year-old South Asian male who developed suspected postural orthostatic tachycardia syndrome (POTS) two weeks after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine booster, which was successfully managed with low-dose fludrocortisone and ivabradine. Clinicians should be aware of the Pfizer-BioNTech COVID-19 vaccine being implicated with the onset of POTS.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963391 | PMC |
| http://dx.doi.org/10.7759/cureus.34236 | DOI Listing |
Publication Analysis
Top Keywords
postural orthostatic
8
orthostatic tachycardia
8
tachycardia syndrome
8
covid-19 vaccine
8
suspected covid-19
4
covid-19 mrna
4
mrna vaccine-induced
4
vaccine-induced postural
4
syndrome case
4
case 15-year-old
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!